Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function

Clinical and Experimental Immunology

Volumn 153, Issue 3, 2008, Pages 439-447

  Sutton, P A ^a,b   Li, S ^a,b   Webb, J ^a,b   Solomon, K ^a,b   Brazier, J ^c   Mahida, Y R ^a,b,d  

^a Immunity and Inflammation   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Anaerobe Reference Unit   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Anti toxin antibody; Colitis; Paracellular permeability

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN A MONOCLONAL ANTIBODY; CLOSTRIDIUM DIFFICILE TOXIN B; DEXTRAN; MONOCLONAL ANTIBODY; SEPHAROSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CACO-2 CELLS; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; EPITHELIAL CELLS; HUMANS; IMMUNOTOXINS; INTESTINAL MUCOSA; INTESTINES; SEPHAROSE; VERO CELLS;

EID: 49649103133     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03690.x     Document Type: Article

References (39)

1. Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988 82 : 1516 24.
2. Mahida YR, Makh S, Hyde S, Gray T, Borriello SP. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 1996 38 : 337 47.
3. Branka JE, Vallette G, Jarry A et al. Early functional effects of Clostridium difficile toxin A on human colonocytes. Gastroenterology 1997 112 : 1887 94.
4. Brito GA, Fujji J, Carneiro-Filho BA, Lima AA, Obrig T, Guerrant RL. Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J Infect Dis 2002 186 : 1438 47.
5. Johal SS, Solomon K, Dodson S, Borriello SP, Mahida YR. Differential effects of varying concentrations of Clostridium difficile toxin A on epithelial barrier function and expression of cytokines. J Infect Dis 2004 189 : 2110 19.
6. Kurtz CB, Cannon EP, Brezzani A et al. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis. Antimicrob Agents Chemother 2001 45 : 2340 7.
7. Maroo S, Lamont JT. Recurrent Clostridium difficile. Gastroenterology 2006 130 : 1311 16.
8. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000 342 : 390 7.
9. Johal SS, Lambert CP, Hammond J, James PD, Borriello SP, Mahida YR. Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea. J Clin Pathol 2004 57 : 973 9.
10. Kink JA, Williams JA. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect Immun 1998 66 : 2018 25.
11. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985 47 : 349 52.
12. Mitchell TJ, Ketley JM, Haslam SC et al. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986 27 : 78 85.
13. Triadafilopoulos G, Pothoulakis C, O'Brien MJ, LaMont JT. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 1987 93 : 273 9.
14. Riegler M, Sedivy R, Pothoulakis C et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995 95 : 2004 11.
15. Savidge TC, Pan WH, Newman P, O'Brien M, Anton PM, Pothoulakis C. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 2003 125 : 413 20.
16. Alfa MJ, Kabani A, Lyerly D et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000 38 : 2706 14.
17. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005 353 : 2433 41.
18. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005 353 : 2442 9.
19. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999 37 : 461 3.
20. Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005 366 : 1079 84.
21. Kamiya S, Reed PJ, Borriello SP. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. J Med Microbiol 1989 30 : 69 77.
22. Solomon K, Webb J, Ali N, Robins RA, Mahida YR. Monocytes are highly sensitive to Clostridium difficile toxin A-induced apoptotic and nonapoptotic cell death. Infect Immun 2005 73 : 1625 34.
23. Beltinger J, McKaig BC, Makh S, Stack WA, Hawkey CJ, Mahida YR. Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response. Am J Physiol 1999 277 (2 Pt 1 C271 9.
24. Lyerly DM, Phelps CJ, Toth J, Wilkins TD. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun 1986 54 : 70 6.
25. Frey SM, Wilkins TD. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun 1992 60 : 2488 92.
26. Price AB, Davies DR. Pseudomembranous colitis. J Clin Pathol 1977 30 : 1 12.
27. Stubbe H, Berdoz J, Kraehenbuhl JP, Corthesy B. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 2000 164 : 1952 60.
28. Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001 2 : 361 7.
29. Niess JH, Brand S, Gu X et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005 307 : 254 8.
30. Souza MH, Melo-Filho AA, Rocha MF et al. The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B. Immunology 1997 91 : 281 8.
31. Bruewer M, Luegering A, Kucharzik T et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003 171 : 6164 72.
32. Marano CW, Lewis SA, Garulacan LA, Soler AP, Mullin JM. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol 1998 161 : 263 74.
33. Zweibaum A, Laburthe M, Grasset E, Louvard D. Use of cultured cell lines in studies of intestinal cell differntiation and function. In : Schultz SG, Field M, Rauner BB, eds. Handbook of physiology. Bethesda, MD : American Physiological Society, 1991 : 223 55.
34. Madara JL, Dharmsathaphorn K. Occluding junction structure-function relationships in a cultured epithelial monolayer. J Cell Biol 1985 101 : 2124 33.
35. van den Berg RJ, Claas EC, Oyib DH et al. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 2004 42 : 1035 41.
36. Pituch H, Brazier JS, Obuch-Woszczatynski P, Wultanska D, Meisel-Mikolajczyk F, Luczak M. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. J Med Microbiol 2006 55 : 207 13.
37. Borriello SP, Wren BW, Hyde S et al. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992 60 : 4192 9.
38. Geric B, Carman RJ, Rupnik M et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006 193 : 1143 50.
39. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986 105 : 883 5.